Literature DB >> 32734668

A British Society for Haematology Guideline on the diagnosis and management of chronic myeloid leukaemia.

Graeme Smith1, Jane Apperley2, Dragana Milojkovic2, Nicholas C P Cross3, Letizia Foroni2, Jenny Byrne4, Andy Goringe5, Anupama Rao6, Jamshid Khorashad2, Hugues de Lavallade7, Adam J Mead8, Wendy Osborne9, Chris Plummer9, Gail Jones9,10, Mhairi Copland11.   

Abstract

Entities:  

Keywords:  BCR-ABL; CML; imatinib; tyrosine kinases

Mesh：

Substances：

Year:  2020        PMID： 32734668     DOI： 10.1111/bjh.16971

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

Review 1.  The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.

Authors:  Guray Saydam; Ridvan Ali; Ahmet Muzaffer Demir; Ahmet Emre Eskazan; Birol Guvenc; Ibrahim Celalettin Haznedaroglu; Mehmet Ali Ozcan; Ozan Salim; Mehmet Sonmez; Ayse Tulin Tuglular; Mehmet Turgut; Ali Unal; Birkan Aver; Sirac Bozkurt; Begum Ozdengulsun; Osman Ilhan
Journal:  Int J Hematol Oncol       Date:  2022-05-24

2.  Interrogating the molecular genetics of chronic myeloproliferative malignancies for personalized management in 2021.

Authors:  Tariq I Mughal; Bethan Psaila; Daniel J DeAngelo; Giuseppe Saglio; Richard A Van Etten; Jerald P Radich
Journal:  Haematologica       Date:  2021-07-01       Impact factor: 9.941

Review 3.  A New Paradigm of Cardio-Hematological Monitoring in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inhibitors.

Authors:  Nataliia Lopina; Iryna Dmytrenko; Dmytro Hamov; Dmytro Lopin; Iryna Dyagil
Journal:  Cureus       Date:  2022-06-08

Review 4.  Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool.

Authors:  Sara Galimberti; Serena Balducci; Francesca Guerrini; Marzia Del Re; Rossella Cacciola
Journal:  Diagnostics (Basel)       Date:  2022-05-24

Review 5.  Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia.

Authors:  Michele Baccarani; Francesca Bonifazi; Simona Soverini; Fausto Castagnetti; Gabriele Gugliotta; Wael Saber; Noel Estrada-Merly; Gianantonio Rosti; Robert Peter Gale
Journal:  Leukemia       Date:  2022-03-25       Impact factor: 12.883
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.